• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

卡介苗对结核分枝杆菌和非结核分枝杆菌感染的保护效力

Protective Efficacy of BCG Vaccine against and Non-Tuberculous Mycobacterial Infections.

作者信息

Orujyan Davit, Narinyan William, Rangarajan Subhapradha, Rangchaikul Patrida, Prasad Chaya, Saviola Beatrice, Venketaraman Vishwanath

机构信息

College of Osteopathic Medicine of the Pacific, Western University of Health Sciences, Pomona, CA 91766, USA.

出版信息

Vaccines (Basel). 2022 Mar 3;10(3):390. doi: 10.3390/vaccines10030390.

DOI:10.3390/vaccines10030390
PMID:35335022
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8952781/
Abstract

The genus mycobacterium includes several species that are known to cause infections in humans. The microorganisms are classified into tuberculous and non-tuberculous based on their morphological characteristics, defined by the dynamic relationship between the host defenses and the infectious agent. Non-tuberculous mycobacteria (NTM) include all the species of mycobacterium other than the ones that cause tuberculosis (TB). The group of NTM contains almost 200 different species and they are found in soil, water, animals-both domestic and wild-milk and food products, and from plumbed water resources such as sewers and showerhead sprays. A systematic review of Medline between 1946 and 2014 showed an 81% decline in TB incidence rates with a simultaneous 94% increase in infections caused by NTM. Prevalence of infections due to NTM has increased relative to infections caused by TB owing to the stringent prevention and control programs in Western countries such as the USA and Canada. While the spread of typical mycobacterial infections such as TB and leprosy involves human contact, NTM seem to spread easily from the environment without the risk of acquiring from a human contact except in the case of in patients with cystic fibrosis, where human transmission as well as transmission through fomites and aerosols has been recorded. NTM are opportunistic in their infectious processes, making immunocompromised individuals such as those with other systemic infections such as HIV, immunodeficiencies, pulmonary disease, or usage of medications such as long-term corticosteroids/TNF-α inhibitors more susceptible. This review provides insight on pathogenesis, treatment, and BCG vaccine efficacy against and some important NTM infections.

摘要

分枝杆菌属包括几种已知可引起人类感染的菌种。这些微生物根据其形态特征分为结核分枝杆菌和非结核分枝杆菌,其形态特征由宿主防御与感染因子之间的动态关系所定义。非结核分枝杆菌(NTM)包括除引起结核病(TB)的分枝杆菌以外的所有分枝杆菌菌种。NTM组包含近200种不同的菌种,它们存在于土壤、水、家养和野生动物、牛奶和食品中,以及来自下水道和淋浴喷头喷雾等管道水资源中。对1946年至2014年间Medline的系统评价显示,结核病发病率下降了81%,同时NTM引起的感染增加了94%。由于美国和加拿大等西方国家严格的预防和控制计划,NTM感染的患病率相对于结核病引起的感染有所增加。虽然结核病和麻风病等典型分枝杆菌感染的传播涉及人与人之间的接触,但NTM似乎很容易从环境中传播,除了囊性纤维化患者外,一般不会通过人与人之间的接触感染,在囊性纤维化患者中,已记录到人际传播以及通过污染物和气溶胶传播。NTM在其感染过程中具有机会性,使免疫功能低下的个体,如患有其他全身感染(如HIV)、免疫缺陷、肺部疾病或使用长期皮质类固醇/TNF-α抑制剂等药物的个体更容易感染。本综述提供了关于发病机制、治疗以及卡介苗对结核病和一些重要NTM感染的疗效的见解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe0f/8952781/1f49618751c1/vaccines-10-00390-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe0f/8952781/773cb97b1753/vaccines-10-00390-g001a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe0f/8952781/1f49618751c1/vaccines-10-00390-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe0f/8952781/773cb97b1753/vaccines-10-00390-g001a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe0f/8952781/1f49618751c1/vaccines-10-00390-g002.jpg

相似文献

1
Protective Efficacy of BCG Vaccine against and Non-Tuberculous Mycobacterial Infections.卡介苗对结核分枝杆菌和非结核分枝杆菌感染的保护效力
Vaccines (Basel). 2022 Mar 3;10(3):390. doi: 10.3390/vaccines10030390.
2
: Environmental Bacterium Turned Clinical Nightmare.环境细菌演变成临床噩梦
Microorganisms. 2019 Mar 22;7(3):90. doi: 10.3390/microorganisms7030090.
3
[Cutaneous and soft skin infections due to non-tuberculous mycobacteria].非结核分枝杆菌引起的皮肤及软组织感染
Enferm Infecc Microbiol Clin. 2010 Jan;28 Suppl 1:46-50. doi: 10.1016/S0213-005X(10)70008-2.
4
Isolation of non-tuberculous mycobacteria among tuberculosis patients, a study from a tertiary care hospital in Lahore, Pakistan.巴基斯坦拉合尔一家三级护理医院的结核病患者中非结核分枝杆菌的分离研究。
BMC Infect Dis. 2021 Apr 24;21(1):381. doi: 10.1186/s12879-021-06086-8.
5
Effects of non-tuberculous mycobacteria on BCG vaccine efficacy: A narrative review.非结核分枝杆菌对卡介苗疫苗效力的影响:一项叙述性综述。
J Clin Tuberc Other Mycobact Dis. 2024 May 4;36:100451. doi: 10.1016/j.jctube.2024.100451. eCollection 2024 Aug.
6
Infection Sources of a Common Non-tuberculous Mycobacterial Pathogen, Complex.常见非结核分枝杆菌病原体复合体的感染源
Front Med (Lausanne). 2017 Mar 7;4:27. doi: 10.3389/fmed.2017.00027. eCollection 2017.
7
The frequency and related factors of non-tuberculosis mycobacteria infections among patients with cystic fibrosis.囊性纤维化患者中非结核分枝杆菌感染的频率及相关因素。
Pediatr Int. 2021 Nov;63(11):1369-1375. doi: 10.1111/ped.14688. Epub 2021 Oct 17.
8
Tuberculosis and non-tuberculous mycobacteria among HIV-infected individuals in Ghana.加纳艾滋病毒感染者中的结核病和非结核分枝杆菌
Trop Med Int Health. 2016 Sep;21(9):1181-90. doi: 10.1111/tmi.12749. Epub 2016 Jul 25.
9
Non-Tuberculous Mycobacteria Interference with BCG-Current Controversies and Future Directions.非结核分枝杆菌对卡介苗的干扰——当前争议与未来方向
Vaccines (Basel). 2020 Nov 16;8(4):688. doi: 10.3390/vaccines8040688.
10
[Evaluation of the distribution of non-tuberculous mycobacteria strains isolated in National Tuberculosis Reference Laboratory in 2009-2010, Turkey].[2009 - 2010年土耳其国家结核病参考实验室分离的非结核分枝杆菌菌株分布评估]
Mikrobiyol Bul. 2012 Oct;46(4):560-7.

引用本文的文献

1
Evaluation of immunoprotective effects of PlpE multi-epitope protein incorporated within the aluminum hydroxide-adjuvanted inactivated vaccine against Pasteurella multocida infection in chickens.评估氢氧化铝佐剂灭活疫苗中包含的PlpE多表位蛋白对鸡多杀性巴氏杆菌感染的免疫保护作用。
Poult Sci. 2025 Jun 14;104(9):105426. doi: 10.1016/j.psj.2025.105426.
2
multi-epitope-based vaccine design for complex species.针对复杂物种的基于多表位的疫苗设计
Front Immunol. 2025 Jun 5;16:1589083. doi: 10.3389/fimmu.2025.1589083. eCollection 2025.
3
Pathogenicity and virulence of .

本文引用的文献

1
After 100 Years of BCG Immunization against Tuberculosis, What Is New and Still Outstanding for This Vaccine?卡介苗免疫预防结核病100年后,这种疫苗有哪些新进展,仍存在哪些突出问题?
Vaccines (Basel). 2021 Dec 31;10(1):57. doi: 10.3390/vaccines10010057.
2
Chronic recalcitrant erythema nodosum leprosum: therapeutic dilemma and role of mycobacterium indicus pranii vaccine.慢性难治性结节性红斑麻风:印度分枝杆菌菌苗的治疗困境和作用。
An Bras Dermatol. 2022 Jan-Feb;97(1):49-53. doi: 10.1016/j.abd.2020.08.032. Epub 2021 Nov 27.
3
Treatment and Evaluation Advances in Leprosy Neuropathy.
.的致病性和毒力
Virulence. 2025 Dec;16(1):2508813. doi: 10.1080/21505594.2025.2508813. Epub 2025 May 26.
4
Vaccines in Dermatology-Present and Future: A Review.皮肤病学中的疫苗:现状与未来综述
Vaccines (Basel). 2025 Jan 26;13(2):125. doi: 10.3390/vaccines13020125.
5
Protective role of Bacillus Calmette-Guérin vaccine in Alzheimer's disease progression: A systematic review and meta-analysis.卡介苗在阿尔茨海默病进展中的保护作用:一项系统评价和荟萃分析。
Heliyon. 2024 Mar 6;10(5):e27425. doi: 10.1016/j.heliyon.2024.e27425. eCollection 2024 Mar 15.
6
ssp. and Crohn's Disease-Diagnostic Microbiological Investigations Can Inform New Therapeutic Approaches.亚种与克罗恩病——诊断性微生物学调查可为新治疗方法提供依据。
Antibiotics (Basel). 2024 Feb 5;13(2):158. doi: 10.3390/antibiotics13020158.
7
Unveiling the Clinical Diversity in Nontuberculous Mycobacteria (NTM) Infections: A Comprehensive Review.揭示非结核分枝杆菌(NTM)感染的临床多样性:一项综合综述
Cureus. 2023 Nov 4;15(11):e48270. doi: 10.7759/cureus.48270. eCollection 2023 Nov.
8
Buruli ulcer in Africa: Geographical distribution, ecology, risk factors, diagnosis, and indigenous plant treatment options - A comprehensive review.非洲的布鲁里溃疡:地理分布、生态学、危险因素、诊断及本土植物治疗方案——全面综述
Heliyon. 2023 Nov 15;9(11):e22018. doi: 10.1016/j.heliyon.2023.e22018. eCollection 2023 Nov.
9
THEME: "Vaccines and Vaccine Adjuvants/Immunomodulators for Infectious Diseases".主题:“用于传染病的疫苗及疫苗佐剂/免疫调节剂”
Vaccines (Basel). 2023 Feb 7;11(2):383. doi: 10.3390/vaccines11020383.
10
Immunogenicity and protection against Mycobacterium avium with a heterologous RNA prime and protein boost vaccine regimen.用异源 RNA 初免和蛋白加强疫苗方案预防鸟分枝杆菌的免疫原性和保护作用。
Tuberculosis (Edinb). 2023 Jan;138:102302. doi: 10.1016/j.tube.2022.102302. Epub 2022 Dec 27.
麻风神经病变的治疗和评估进展。
Neurotherapeutics. 2021 Oct;18(4):2337-2350. doi: 10.1007/s13311-021-01153-z. Epub 2021 Nov 19.
4
Exploring Potential COPD Immunosuppression Pathways Causing Increased Susceptibility for MAC Infections among COPD Patients.探索慢性阻塞性肺疾病(COPD)导致患者对鸟分枝杆菌复合群(MAC)感染易感性增加的潜在免疫抑制途径。
Clin Pract. 2021 Sep 9;11(3):619-630. doi: 10.3390/clinpract11030077.
5
100 years of Mycobacterium bovis bacille Calmette-Guérin.牛分枝杆菌卡介苗百年史。
Lancet Infect Dis. 2022 Jan;22(1):e2-e12. doi: 10.1016/S1473-3099(21)00403-5. Epub 2021 Sep 7.
6
Non-tuberculous cutaneous mycobacterioses.非结核性皮肤分枝杆菌病。
An Bras Dermatol. 2021 Sep-Oct;96(5):527-538. doi: 10.1016/j.abd.2021.04.005. Epub 2021 Jul 16.
7
The combination of photodynamic therapy and fractional CO laser for mycobacterium marinum infection.光动力疗法联合 CO2 点阵激光治疗海分枝杆菌感染。
Photodiagnosis Photodyn Ther. 2021 Sep;35:102391. doi: 10.1016/j.pdpdt.2021.102391. Epub 2021 Jun 11.
8
Systematic review of M. Bovis BCG and other candidate vaccines for Buruli ulcer prophylaxis.对用于预防布鲁里溃疡的卡介苗及其他候选疫苗的系统评价。
Vaccine. 2021 Dec 8;39(50):7238-7252. doi: 10.1016/j.vaccine.2021.05.092. Epub 2021 Jun 10.
9
Natural antioxidants attenuate mycolactone toxicity to RAW 264.7 macrophages.天然抗氧化剂可减轻美拉诺林毒素对 RAW 264.7 巨噬细胞的毒性。
Exp Biol Med (Maywood). 2021 Sep;246(17):1884-1894. doi: 10.1177/15353702211015628. Epub 2021 May 26.
10
Subunit vaccine protects against a clinical isolate of Mycobacterium avium in wild type and immunocompromised mouse models.亚单位疫苗可预防野生型和免疫功能低下的小鼠模型中的临床分离分枝杆菌。
Sci Rep. 2021 Apr 27;11(1):9040. doi: 10.1038/s41598-021-88291-8.